ADMA Biologics Inc Other Operating Income or Expenses 2013-2024 | ADMA
ADMA Biologics Inc other operating income or expenses for the twelve months ending September 30, 2024 were $-0.004B, a 57.84% decline year-over-year.
- ADMA Biologics Inc annual other operating income or expenses for 2023 were $-0.004B, a 76.09% decline from 2022.
- ADMA Biologics Inc annual other operating income or expenses for 2022 were $-0.018B, a 45.19% increase from 2021.
- ADMA Biologics Inc annual other operating income or expenses for 2021 were $-0.012B, a 194.7% increase from 2020.